EU-backed projects join forces to tackle obesity crisis

Over the past decades, obesity has reached epidemic proportions, now affecting more than 1 billion people worldwide.

FDA issues second CRL to Supernus for Parkinson’s drug-device combo

It seems Supernus Pharmaceuticals will need a super effort to get its Parkinson’s treatment approved. The FDA rejected the company’s therapy for a second time

April 9, 2024

Biden defends Trump-era drug pricing rule on copay accumulators

WASHINGTON — The Biden administration is appealing a court ruling against a Trump-era regulation that aimed to protect the way health insurance companies handle some

November 29, 2023

Opinion | ‘It’s Not a First-World Problem’: What We Heard This Week

“It’s not a first-world problem and it’s not a Western-world problem.” — Punith Kempegowda, MBBS, MD, PhD, MSc, of the University of Birmingham in England,

June 26, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.